tiprankstipranks
Trending News
More News >
Diagnos (TSE:ADK)
:ADK
Canadian Market

Diagnos (ADK) Stock Statistics & Valuation Metrics

Compare
21 Followers

Total Valuation

Diagnos has a market cap or net worth of C$20.88M. The enterprise value is ―.
Market CapC$20.88M
Enterprise Value

Share Statistics

Diagnos has 101,862,976 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding101,862,976
Owned by Insiders
Owned by Institutions

Financial Efficiency

Diagnos’s return on equity (ROE) is 1.02 and return on invested capital (ROIC) is -2007.95%.
Return on Equity (ROE)1.02
Return on Assets (ROA)-4.70
Return on Invested Capital (ROIC)-2007.95%
Return on Capital Employed (ROCE)2.80
Revenue Per Employee10.63K
Profits Per Employee-195.04K
Employee Count16
Asset Turnover0.26
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Diagnos is -6.42. Diagnos’s PEG ratio is 1.93.
PE Ratio-6.42
PS Ratio0.00
PB Ratio-62.85
Price to Fair Value-6.56
Price to FCF-10.77
Price to Operating Cash Flow-10.03
PEG Ratio1.93

Income Statement

In the last 12 months, Diagnos had revenue of 170.16K and earned -3.12M in profits. Earnings per share was -0.04.
Revenue170.16K
Gross Profit35.80K
Operating Income-2.69M
Pretax Income-3.12M
Net Income-3.12M
EBITDA-2.45M
Earnings Per Share (EPS)-0.04

Cash Flow

In the last 12 months, operating cash flow was -2.99M and capital expenditures -13.21K, giving a free cash flow of -3.00M billion.
Operating Cash Flow-2.99M
Free Cash Flow-3.00M
Free Cash Flow per Share-0.03

Dividends & Yields

Diagnos pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.12
52-Week Price Change-35.48%
50-Day Moving Average0.25
200-Day Moving Average0.31
Relative Strength Index (RSI)26.32
Average Volume (3m)101.56K

Important Dates

Diagnos upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateMay 28, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend Date

Financial Position

Diagnos as a current ratio of 0.25, with Debt / Equity ratio of -688.63%
Current Ratio0.25
Quick Ratio0.25
Debt to Market Cap0.15
Net Debt to EBITDA-1.21
Interest Coverage Ratio-4.88

Taxes

In the past 12 months, Diagnos has paid 1.00 in taxes.
Income Tax1.00
Effective Tax Rate>-0.01

Enterprise Valuation

Diagnos EV to EBITDA ratio is -9.40, with an EV/FCF ratio of -10.65.
EV to Sales135.12
EV to EBITDA-9.40
EV to Free Cash Flow-10.65
EV to Operating Cash Flow-10.71

Balance Sheet

Diagnos has C$2.82M in cash and marketable securities with C$3.29M in debt, giving a net cash position of C$465.74K billion.
Cash & Marketable SecuritiesC$2.82M
Total DebtC$3.29M
Net CashC$465.74K
Net Cash Per Share<C$0.01
Tangible Book Value Per Share-C$0.04

Margins

Gross margin is -683.97%, with operating margin of -1578.00%, and net profit margin of -1833.93%.
Gross Margin-683.97%
Operating Margin-1578.00%
Pretax Margin-1833.93%
Net Profit Margin-1833.93%
EBITDA Margin-1437.61%
EBIT Margin-1510.60%

Analyst Forecast

The average price target for Diagnos is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-35.15%
EPS Growth Forecast-6.59%

Scores

Smart Score2
AI Score24
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis